




Searching News Database: Horizon Pharma
HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
HSMN NewsFeed - 24 Jan 2018
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
Advicenne Appoints Linda Law, MD as US Vice President, Clinical Development and Medical Affairs
HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
HSMN NewsFeed - 15 May 2017
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
HSMN NewsFeed - 4 Apr 2016
Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development
Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development
HSMN NewsFeed - 4 Feb 2016
GTCR Announces Third Partnership with Ed Fiorentino to Form TerSera(TM) Therapeutics
GTCR Announces Third Partnership with Ed Fiorentino to Form TerSera(TM) Therapeutics
HSMN NewsFeed - 30 Mar 2015
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
HSMN NewsFeed - 13 Nov 2014
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
HSMN NewsFeed - 19 Mar 2014
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
HSMN NewsFeed - 5 Mar 2014
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer
HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
HSMN NewsFeed - 19 Nov 2013
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
HSMN NewsFeed - 22 Aug 2013
Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
HSMN NewsFeed - 18 Sep 2012
Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
HSMN NewsFeed - 20 Jan 2012
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Additional items found! 18

Members Archive contains
18 additional stories matching:
Horizon Pharma
(Password required)
Horizon Pharma
(Password required)